Nanollose Limited (NC6.AX)

AUD 0.04

(0.0%)

Operating Expenses Summary of Nanollose Limited

  • Nanollose Limited's latest annual operating expenses in 2024 was 12.5 Thousand AUD , down -99.06% from previous year.
  • Nanollose Limited's latest quarterly operating expenses in 2024 FY was 656.81 Thousand AUD , down -7.73% from previous quarter.
  • Nanollose Limited reported a annual operating expenses of 1.33 Million AUD in annual operating expenses 2023, down -58.44% from previous year.
  • Nanollose Limited reported a annual operating expenses of 1.48 Million AUD in annual operating expenses 2022, up 46.21% from previous year.
  • Nanollose Limited reported a quarterly operating expenses of 377.04 Thousand AUD for 2024 Q2, up 6.87% from previous quarter.
  • Nanollose Limited reported a quarterly operating expenses of 510.63 Thousand AUD for 2024 Q4, down -25.1% from previous quarter.

Annual Operating Expenses Chart of Nanollose Limited (2024 - 2015)

Historical Annual Operating Expenses of Nanollose Limited (2024 - 2015)

Year Operating Expenses Operating Expenses Growth
2024 12.5 Thousand AUD -99.06%
2023 1.33 Million AUD -58.44%
2022 1.48 Million AUD 46.21%
2021 1 Million AUD -32.91%
2020 1.58 Million AUD -22.48%
2019 2.05 Million AUD 18.93%
2018 1.73 Million AUD 131.69%
2017 756.98 Thousand AUD 3785.32%
2016 14.69 Thousand AUD 914.42%
2015 1048.00 AUD 0.0%

Peer Operating Expenses Comparison of Nanollose Limited

Name Operating Expenses Operating Expenses Difference
AdAlta Limited 6.76 Million AUD 99.815%
Acrux Limited 8.55 Million AUD 99.854%
Actinogen Medical Limited 22.77 Million AUD 99.945%
AnteoTech Limited 12.18 Million AUD 99.897%
Argenica Therapeutics Limited 8.26 Million AUD 99.849%
Arovella Therapeutics Limited 10.78 Million AUD 99.884%
Anatara Lifesciences Ltd 710.21 Thousand AUD 98.24%
Alterity Therapeutics Limited 23.4 Million AUD 99.947%
Amplia Therapeutics Limited 8.43 Million AUD 99.852%
Avecho Biotechnology Limited 4.54 Million AUD 99.725%
Bio-Gene Technology Limited 2.76 Million AUD 99.547%
Biome Australia Limited 7.91 Million AUD 99.842%
Biotron Limited 5.11 Million AUD 99.755%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD 97.923%
BTC Health Limited -1.03 Million AUD 101.203%
Chimeric Therapeutics Limited 19.76 Million AUD 99.937%
CSL Limited 7.56 Billion AUD 100.0%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 99.978%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 99.96%
Cynata Therapeutics Limited 11.12 Million AUD 99.888%
Dimerix Limited 25.64 Million AUD 99.951%
EZZ Life Science Holdings Limited 39.57 Million AUD 99.968%
Hexima Limited 1 Million AUD 98.761%
Island Pharmaceuticals Limited 4.12 Million AUD 99.697%
Immuron Limited 9.13 Million AUD 99.863%
Immutep Limited 42.87 Million AUD 99.971%
Imugene Limited 135.09 Million AUD 99.991%
Invex Therapeutics Ltd 3.34 Million AUD 99.626%
Memphasys Limited 3.67 Million AUD 99.66%
Neuren Pharmaceuticals Limited 32.69 Million AUD 99.962%
Noxopharm Limited 7 Million AUD 99.821%
NeuroScientific Biopharmaceuticals Limited 1.96 Million AUD 99.364%
Nyrada Inc. 4.55 Million AUD 99.726%
Orthocell Limited 15.36 Million AUD 99.919%
PharmAust Limited 6.65 Million AUD 99.812%
Patrys Limited 4.93 Million AUD 99.747%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 99.981%
Proteomics International Laboratories Limited 892.14 Thousand AUD 98.599%
Prescient Therapeutics Limited 10.89 Million AUD 99.885%
PYC Therapeutics Limited 60.91 Million AUD 99.979%
Race Oncology Limited 14.77 Million AUD 99.915%
Radiopharm Theranostics Limited 299.22 Thousand AUD 95.822%
Recce Pharmaceuticals Ltd 21.68 Million AUD 99.942%
Starpharma Holdings Limited 22.81 Million AUD 99.945%
Telix Pharmaceuticals Limited 269.26 Million AUD 99.995%
Tissue Repair Ltd 6.66 Million AUD 99.812%
Zelira Therapeutics Limited 5.94 Million AUD 99.79%